| Date Filed | Type | Description |
| 02/14/2014 |
SC 13G/A
| MERITECH CAPITAL PARTNERS II LP reports a 0% stake in Solta Medical, Inc. |
| 02/13/2014 |
SC 13G/A
| Broadfin Capital, LLC reports a 4.2% stake in Solta Medical, Inc.. |
| 02/12/2014 |
SC 13G/A
| Longitude Capital Partners, LLC reports a 0% stake in Solta Medical, Inc. |
| 02/06/2014 |
SC 13G/A
| DELPHI VENTURES VII L P reports a 0.9% stake in Solta Medical, Inc. |
| 01/27/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2014 |
4
| McCarthy Cathy L (Director) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| Holthe David (Director) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| Graebner Linda (Director) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| COVERT HAROLD L (Director) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Unknown transaction of 74,602 shares
@ $2.92, valued at
$217.8k
Disposed/sold 25,000 options to buy
@ $1.39, valued at
$34.8k
Disposed/sold 25,000 options to buy
@ $2.47, valued at
$61.8k
|
|
| 01/27/2014 |
4
| Ku Mingo (Vice President of Global Sales) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| Parr Lisa D (VP Regulatory/Clinical Affairs) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Disposed/sold 3,524 shares
@ $2.92, valued at
$10.3k
Disposed/sold 100,000 options to buy
@ $2.77, valued at
$277k
|
|
| 01/27/2014 |
4
| Nardoci Jeffrey C (VP Worldwide Mktg/GM Surg Supp) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| Heigel Douglas W (VP Operations) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| Ferrari H Daniel (Vice President of Finance) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| GLENN JOHN (CFO) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/27/2014 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC |
| 01/24/2014 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...|
Docs:
|
"Amended and Restated Certificate of Incorporation of Solta Medical, Inc",
"Amended and Restated By-laws of Solta Medical, Inc",
"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. COMPLETES ACQUISITION OF SOLTA MEDICAL, INC. Laval, Quebec — January 23, 2014 — Valeant Pharmaceuticals International, Inc. today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International would acquire Solta Medical, Inc. at a price of $2.92 per share in cash, or approximately $250 million in the aggregate. On January 23, 2014, Valeant announced that it had successfully completed the tender offer for all outstanding shares of common stock of Solta. Valeant announced that it had accepted for payment all shares validly tendered and not properly withdrawn as of the expiration time of the tender offer and would promptly pay for such shares, which represented approxim..." |
|
| 01/23/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/23/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/15/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/15/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/13/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/13/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/02/2014 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC |
| 12/23/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 12/23/2013 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 12/16/2013 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/16/2013 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Sapphire Subsidiary Corp., Valeant Pharmaceuticals International, Inc. and Solta Medical, Inc",
"VALEANT PHARMACEUTICALS AGREES TO ACQUIRE SOLTA MEDICAL FOR $2.92 PER SHARE IN CASH Combination Creates a Global Leader in Aesthetics Transaction Values Solta at Approximately $250 Million Transaction Expected to Close in the First Quarter of 2014 Laval, Quebec and Hayward, Calif. — December 16, 2013 — Valeant Pharmaceuticals International, Inc. today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Solta Medical, Inc. for $2.92 per share in cash, which represents a 40% premium to Solta's closing share price on December 13, 2013, the last trading day prior to announcement, or a transaction value of approximately $250 million. The transaction is expected to close in the first quarter of 2014 and Valeant expects..." |
|
| 12/16/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/10/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/03/2013 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Granted 10,095 shares
@ $0 |
|
| 12/03/2013 |
8-K
| Quarterly results |
| 11/22/2013 |
4
| Heigel Douglas W (VP Operations) has filed a Form 4 on SOLTA MEDICAL INC |
| 11/15/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
|